Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Colorectal cancer screening interval after negative colonoscopy

The latest issue of Surgical Endoscopy investigaates the correct screening interval for colorectal cancer after negative colonoscopy.

News image

Despite the high sensitivity of screening colonoscopy, polyps and cancers can still go undetected.

With the polyp-to-cancer transformation cycle averaging 710 years, present guidelines recommend repeat colonoscopy within 10 years after negative screening.

However, not all colorectal malignancies follow this decade-long progression.

Dr Steven Nakao and colleagues evaluated the incidence and pathology of colorectal cancers following a previous negative screening colonoscopy.

Records of patients who underwent a colectomy at our institution, from 1998 to 2009, were reviewed retrospectively.

The researchers reported that a total of 1,784 patient records were screened using exclusion criteria for inclusion in this study.

Group 1 included patients with a negative colonoscopy within the previous 5 years.

Group 2 included patients without a previous colonoscopy or with a previous colonoscopy more than 5 years prior.

Group 1 patients were evaluated by colonoscopy for anemia, diverticulitis, signs of obstruction, and bleeding.

Age, tumor location, operation performed, and pathology findings were recorded.

The team of researchers assessd that the χ2 test and paired t test were used for statistical analysis.

A total of 233 patients were included in this study.

18% developed colorectal cancer
Surgical Endoscopy

Group 1 contained 43 patients with a mean age of 73 years.

Group 2 had 190 patients with a mean age of 68 years.

The team of doctors noted that group 1 consisted of 18 male and 25 female patients, and Group 2 included 94 male and 96 female patients.

Both groups were further classified into age categories including 50 years, 5080 years, and 80 years.

The research team noted that 18% of the total study population had newly discovered colorectal cancer within a 5-year colonoscopy screening period.

There were no significant differences in the distribution of the T and N stages between the 2 groups, and no statistically significant differences when the rate of lymphovascular invasion and perineural invasion were compared.

Within 5 years, 18% developed colorectal cancer.

Dr Nakao's team commented "Most of these malignancies were found within the 5080-year age group and located predominantly in the right colon and distally in the sigmoid and rectum."

"While distal cancers may be visualized by flexible sigmoidoscopy, those located more proximally may be missed, necessitating the need for a full colonoscopy."

"Although staging was similar between the two groups, Group 1 tumors were less aggressive despite having appeared within 5 years."

"As a result of our incidence of colorectal cancer within a 5-year interval, a shorter period for routine colonoscopy may be considered."

Surgical Endoscopy 2013: 3(27): 768-773
01 April 2013

Go to top of page Email this page Email this page to a colleague

 22 May 2015

Advanced search
 22 May 2015 
Treatment with anti-integrin antibodies in IBD
 22 May 2015 
Care of patients with GERD
 22 May 2015 
Colonoscopy screening for colorectal cancer
 21 May 2015 
Imaging for hepatocellular carcinoma
 21 May 2015 
Lymphoma in IBD
 21 May 2015 
Serrated polyps and colorectal cancer
 20 May 2015 
Refractory metastatic colorectal cancer
 20 May 2015 
Pancreatic neuroendocrine tumors
 20 May 2015 
Surveillance in long-segment Barrett's
 19 May 2015 
PPIs and cryptogenic liver abscess
 19 May 2015 
Anti-integrin antibodies in IBD
 19 May 2015 
Metabolic syndrome and Barrett's
 18 May 2015 
HLA haplotypes and primary sclerosing cholangitis
 18 May 2015 
Safety of PPI
 18 May 2015 
ESPGHAN celiac guidelines
 15 May 2015 
Management of nonhospitalized ulcerative colitis
 15 May 2015 
Diabetes and infections in IBD with immunomodulation
 15 May 2015 
Microscopic colitis risk with PPIs/NSAIDs
 14 May 2015 
Diagnosis of spontaneous bacterial peritonitis
 14 May 2015 
Mortality in US patients with cirrhosis
 14 May 2015 
Radiation exposure during ERCP
 13 May 2015 
Predictors of IBD
 13 May 2015 
Psychological distress and liver disease mortality
 13 May 2015 
Hypnotherapy in IBS/IBD
 12 May 2015 
Bleeding in NSAID users with H.pylori
 12 May 2015 
Capsule colonoscopy detects colorectal polyps
 12 May 2015 
Anti-TNF biologics in acute severe ulcerative colitis
 11 May 2015 
Management of Barrett's esophagus
 11 May 2015 
Marker to detect recurrence of Crohn's
 11 May 2015 
Thalidomide for IBD
 08 May 2015 
Surveillance colonoscopy in colorectal cancer
 08 May 2015 
HCV treatment with compensated cirrhosis
 08 May 2015 
Medical management of Crohn's
 07 May 2015 
Surgical complications in ulcerative colitis
 07 May 2015 
Combination therapy for noncirrhostic patients
 07 May 2015 
Anxiety and new-onset dyspepsia
 06 May 2015 
PPIs and spontaneous bacterial peritonitis
 06 May 2015 
Infant feeding and celiac disease
 06 May 2015 
Preventing recurrent C. diff infection
 05 May 2015 
Fatigue in primary sclerosing cholangitis
 05 May 2015 
Annual CT scans after esophagectomy for cancer
 05 May 2015 
Prevalence of eosinophilic esophagitis
 04 May 2015 
Stress resilience and peptic ulcer disease
 04 May 2015 
Endoscope storage and microbial colonization
 04 May 2015 
Menarche and NAFLD
 01 May 2015 
Sleep and physical activity measured in Crohn's
 01 May 2015 
NAFLD progression from steatosis to fibrosing-steatohepatitis
 01 May 2015 
Dietary supplement hepatotoxicity
 30 April 2015 
Botulinum toxin A for the treatment of obesity
 30 April 2015 
Risk factors for primary sclerosing cholangitis
 30 April 2015 
Neoadjuvant chemoradiotherapy for esophageal cancer
 29 April 2015 
Liver enzyme elevations after anti-TNF therapy in IBD

 29 April 2015 
Hepatocellular carcinoma surveillance in HBV
 29 April 2015 
Response to sorafenib in hepatocellular carcinoma
 28 April 2015 
Risk factors of hepatocellular carcinoma
 28 April 2015 
Clinical outcomes after esophagectomy
 28 April 2015 
Alcohol drinking and risk of liver cirrhosis
 23 April 2015 
Gut microbiota modulation for alcoholic liver disease
 23 April 2015 
Moderate sodium restriction diet in cirrhosis
 23 April 2015 
Gastroesophageal junction disruption and obesity

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us